Launch week offerEnds in00h00m00s

annual Promonthly Pro

Kartik Sehgal

Medical Oncologist

Dana-Farber Cancer Institute

United States

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (20)

Collaborators (6)

Lucas A Salas

Assistant Professor

Dartmouth College Geisel School of Medicine

UNITED STATES

Sarina Piha-Paul

The University of Texas MD Anderson Cancer Center

UNITED STATES

Bruno Bockorny

Beth Israel Deaconess Medical Center

UNITED STATES

Glenn Hanna

Dana-Farber Cancer Institute

UNITED STATES

ravindra uppaluri

Dana-Farber Cancer Institute

UNITED STATES

Patrick Gedeon

Dana-Farber Cancer Institute

UNITED STATES

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Kartik Sehgal

Research Interests

Make your next move.

Explore related searches

Articles (20)

Collaborators (6)

Lucas A Salas

Sarina Piha-Paul

Bruno Bockorny

Glenn Hanna

ravindra uppaluri

Patrick Gedeon

Make your next move.

Kartik Sehgal

Research Interests

Make your next move.

Explore related searches

Articles (20)

Elraglusib, a Glycogen Synthase Kinase 3β Inhibitor, plus Chemotherapy with or without Immunotherapy in Patients with Recurrent, Metastatic Salivary Gland Carcinoma

PTPN2 inhibition unleashes response to STING agonism in head and neck squamous cell cancer

First-in-Human, Phase I Study of Sigvotatug Vedotin, an Integrin Beta-6–Directed Antibody-Drug Conjugate: Results From Dose Expansion in Advanced Non–Small Cell Lung Cancer

Tarlatamab: Precision Delta-Like Ligand 3 Bispecific T-Cell Engager for Malignancies Beyond De Novo Small Cell Lung Cancer?

Preliminary Safety and Efficacy of Tarlatamab in Medullary Thyroid Carcinoma

Decoding tumor microenvironment and resistance following immune checkpoint inhibition therapy in anaplastic thyroid carcinoma

A Prospective Trial of Biomarker-Guided Surveillance for HPV-Positive Oropharynx Cancer Using Plasma Tumor Tissue–Modified Viral HPV DNA

Duvelisib with Docetaxel for Patients with Anti–PD-1 Refractory, Recurrent, or Metastatic Head and Neck Squamous Cell Carcinoma

Personalized Thyroidology: Molecular Rewiring of Thyroid Nodule Management

A Phase I/II Trial of Sapanisertib in Advanced Anaplastic and Radioiodine Refractory Differentiated Thyroid Carcinoma

A cytokine-based serum proteomic score is a prognostic biomarker for immunotherapy in head and neck cancer

A phase 2 clinical trial of adjuvant ado-trastuzumab emtansine (T-DM1) for patients with HER2-positive salivary gland cancer.

A phase 2 clinical trial of preoperative pembrolizumab and chemotherapy followed by adjuvant pembrolizumab in resectable locoregionally recurrent head and neck squamous cell carcinoma.

Blood DNA methylation in association with immune checkpoint inhibitor related outcomes among patients with head and neck squamous cell carcinoma

Dual immune checkpoint inhibition in advanced incurable radioidine-refractory differentiated thyroid carcinoma (RAIR DTC), anaplastic (ATC), and medullary thyroid carcinoma (MTC): Long-term survival results from phase II clinical trial.

Dynamic proteomic biomarkers of survival outcomes with anti-PD-1 immunotherapy in head and neck squamous cell carcinoma

Elraglusib, a glycogen synthase kinase 3 beta (GSK 3ß) inhibitor, plus chemotherapy with or without immunotherapy for advanced salivary gland cancer Free

Risk-adapted therapy guided by human papillomavirus (HPV) circulating tumor DNA in patients with HPV-positive oropharyngeal cancer (ReACT 1.0)

Sigvotatug vedotin (SV), an investigational integrin beta-6 (IB6)-directed antibody-drug conjugate (ADC), and pembrolizumab combination therapy: Initial results from an ongoing phase 1 study (SGNB6A-001).

Methylation cytometric pretreatment blood immune profiles with tumor mutation burden as prognostic indicators for survival outcomes in head and neck cancer patients on anti-PD-1 therapy.

Collaborators (6)

Lucas A Salas

Sarina Piha-Paul

Bruno Bockorny

Glenn Hanna

ravindra uppaluri

Patrick Gedeon

Make your next move.